FIELD: chemistry.
SUBSTANCE: present invention relates to new nitroxide compounds with formula I: where one of A, B and D represents N-O and others represent CR6; R1 represents alkyl, containing 1 to 4 carbon atoms, which is branched or straight and which is unsubstituted or substituted once or several times with a halogen; R2 represents alkyl, containing 1 to 12 carbon atoms, which is branched or straight and which is unsubstituted or substituted once or several times with a halogen; cycloalkylalkylk, containing 3 to 10 carbon atoms, which is unsubstituted or substituted once or several times with oxo, aryl, containing 6 to 14 carbon atoms, which is unsubstituted or substituted once or several times with OCF3; or a heterocyclic group, which is saturated, partially saturated or unsaturated, with 5 to 10 atoms in the ring, where at least 1 atom in the ring is an atom of N, O, or S; R3 represents cycloalkyl, containing 3 to 10 carbon atoms, which is unsubstituted once or several times with oxo, aryl, containing from 6 to 14 carbon atoms or which is unsubstituted or substituted once or several times with OCF3; or heteroaryl, with 5 to 10 atoms in the ring, in which at least 1 atom in the ring is a heteroatom; R represents H or alkyl, containing 1 to 4 carbon atoms. The invention also relates to pharmaceutically used salts of these compounds, pharmaceutical compositions containing these compounds, method of inhibiting PDE4 enzyme and to methods treatment using these compounds.
EFFECT: new compounds with useful biological properties.
62 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
USING DERIVATIVES OF ANILINE AS PHOSPHODIESTERASE-4 INHIBITORS | 2002 |
|
RU2321583C2 |
6-AMINO-1H-INDAZOLE AND 4-AMINOBENZOFURAN COMPOUNDS AS PHOSPHODIESTERASE 4 INHIBITORS | 2003 |
|
RU2354648C2 |
INHIBITORS OF PHOSPHODIESTERASE 4 CONTAINING N-SUBSTITUTED DIARYLAMINE ANALOGUES | 2004 |
|
RU2388750C2 |
OPTIONALLY CONDENSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES SUITABLE FOR TREATING INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2734261C2 |
PYRAZOLE DERIVATIVES AS PHOSPHODIESTERASE 4 INHIBITORS | 2004 |
|
RU2379292C2 |
DERIVATIVES OF 4-(4-ALKOXY-3-HYDROXYPHENYL)-2-PYRROLIDONE AS PDE-4 INHIBITORS FOR TREATMENT OF NEUROLOGICAL SYNDROMES | 2002 |
|
RU2340600C2 |
COUMARONE DERIVATIVES ELICITING COMT-INHIBITING ACTIVITY | 2001 |
|
RU2282627C2 |
SACCHARIN DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE ACID OR BASE ADDITIVE SALT, PHARMACEUTICAL COMPOSITION EXHIBITING ACTIVITY OF ELASTASE INHIBITOR | 1992 |
|
RU2114835C1 |
OPTIONALLY CONDENSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES SUITABLE FOR TREATING INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2719422C2 |
DIKETONE AS INTERMEDIATE FOR 3-HALOGENE-1H-PYRASOLES | 1996 |
|
RU2251543C2 |
Authors
Dates
2009-05-27—Published
2003-11-19—Filed